Estimation of Delafloxacin Using Derivative Spectrophotometry and Area Under Curve in Bulk Material and in Laboratory Mixture

Abstract

Simple, specific, rapid and accurate UV-spectrophotometric methods have been developed using a solvent acetonitrile (50 %) to determine delafloxacin in bulk material and in laboratory mixture. “Method A” is zero order derivative UV- spectrophotometry using absorbance, “Method B” is zero order derivative UV-spectrophotometry using Area Under Curve (AUC) technique, “Method C” is first order derivative UV-spectrophotometry using amplitude, “Method D” is First Order Derivative UV-spectrophotometry- AUC,“Method E” is Second Order Derivative UV-spectrophotometry using amplitude and “Method F” is second order derivative UV- spectrophotometry using (AUC) technique. The developed methods have shown excellent results in terms of linearity and range, accuracy, precision and Limit of Detection (LOD) and Limit of Quantification (LOQ). In all Methods, delafloxacin obeyed linearity in the concentration range of 2 - 12 μg/mL with (r2 > 0.999). All these methods were applied for estimation of delafloxacin in laboratory mixture. All the above mentioned methods were validated considering linearity and range, accuracy, precision, ruggedness and sensitivity.

  • Page Number : 81-87
  • Keywords
    Delafloxacin, UV-Spectrophotometry, Zero order Derivative, First order Derivative, Area under curve, Second Order Derivative
  • DOI Number
    10.15415/jptrm.2016.41006
  • Authors
    • Kiran R. Dhangar R.C. Patel Institute of Pharmaceutical Education and Research, Dhule, Maharashtra, India
    • Atul A. Shirkhedkar R.C. Patel Institute of Pharmaceutical Education and Research, Dhule, Maharashtra, India

References

  • Abida, M. Imran, M. A. M. Hagga, S. A. El-Feky., (2014), New chemical entities of future for infectious diseases, European Journal of Experimental Biology, 4(1), 613–624.
  • Bassetti M, Della Siega P, Pecori D, Scarparo C, Righi E., (2015), Delafloxacin for the treatment of respiratory and skin infections. Expert Opinion Investigational Drugs, 24(3), 433–442. http://dx.doi.org/10.1517/13543784.2015.1005205
  • ICH Harmonized Tripartite Guideline, Q2 (R1): Validation of Analytical Procedures: Text and Methodology, International Conference on Harmonization, Geneva, Switzerland, 2005.
  • McEwen, L. Lawrence, R. Hoover, L. Stevens, S. Mair, G. Ford, et al, (2015),Disposition, metabolism and mass balance of delafloxacin in healthy human volunteers following intravenous administration, Xenobiotica, 1-9, doi:10.3109/00498254.2015.1042946. http://dx.doi.org/10.3109/00498254.2015.1042946
  • S. Chalikwar, A. Shirkhedkar, M. Bagul, P. Jain, S. Surana, (2012), Development and validation of zero and first-order derivative area under curve spectrophotometric methods for the determination of entacapone in bulk material and in tablets. Pharmceutical Methods, 3(1), 14–17. http://dx.doi.org/10.4103/2229-4708.97709
  • Van Bambeke F., (2015), Delafloxacin, a non-zwitterionic fluoroquinolone in Phase III of clinical development: evaluation of its pharmacology, pharmacokinetics, pharmacodynamics and clinical efficacy. Future Microbiology, 10(7), 1111–23. http://dx.doi.org/10.2217/fmb.15.39

  • Published Date : 2016-05-07